These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6926777)

  • 1. Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease.
    Bryceson AD; Woestenborghs R; Michiels M; van den Bossche H
    Trans R Soc Trop Med Hyg; 1982; 76(4):563-4. PubMed ID: 6926777
    [No Abstract]   [Full Text] [Related]  

  • 2. Echinococcus granulosus: permeability of hydatid cysts to mebendazole in mice.
    Kammerer WS; Miller KL
    Int J Parasitol; 1981 Jun; 11(3):183-5. PubMed ID: 7275474
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyst and host tissue concentrations of mebendazole in patients undergoing surgery for hydatid disease.
    Braithwaite PA; Allan RJ; Dawson M; Roberts MS; Watson TR
    Med J Aust; 1983 Oct; 2(8):383-4. PubMed ID: 6621485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dose form on the bioavailability of mebendazole in man.
    Dawson M; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):87-90. PubMed ID: 3978024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Distribution and excretion of mebendazole in albino mice with experimental alveococcosis].
    Lur'e AA; Soprunova NIa; Krotov AI
    Med Parazitol (Mosk); 1978; 47(2):59-62. PubMed ID: 651814
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with mebendazole in the treatment of inoperable hydatid disease in England.
    Bryceson AD; Cowie AG; Macleod C; White S; Edwards D; Smyth JD; McManus DP
    Trans R Soc Trop Med Hyg; 1982; 76(4):510-8. PubMed ID: 6926770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental chemotherapy of alveococcosis. 9. The pharmacokinetics and effectiveness of mebendazole when administered by peroral and intramuscular routes to infected mice].
    Dzhabarova VI; Lur'e AA; Krotov AI
    Med Parazitol (Mosk); 1986; (5):63-7. PubMed ID: 3796458
    [No Abstract]   [Full Text] [Related]  

  • 8. Mebendazole and hydatid disease.
    Bryceson A
    Br Med J; 1980 Mar; 280(6216):796. PubMed ID: 7370670
    [No Abstract]   [Full Text] [Related]  

  • 9. [The enhanced bioavailability of mebendazole in echinococcosis patients when used with Essentiale].
    Shcherbakov AM; Lur'e AA
    Med Parazitol (Mosk); 1993; (1):43-5. PubMed ID: 8336653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experimental study of the chemotherapy of echinococcosis using intramuscular injections of a mebendazole suspension].
    Krotov AI; Dzhabarova VI; Pereverzeva EV; Lopatin BV; Dobrotvorskiĭ AE
    Med Parazitol (Mosk); 1983; (5):61-3. PubMed ID: 6646057
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease.
    Morris DL; Gould SE
    Br Med J (Clin Res Ed); 1982 Jul; 285(6336):175. PubMed ID: 6807398
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics and bioavailability of mebendazole in man: a pilot study using [3H]-mebendazole.
    Dawson M; Allan RJ; Watson TR
    Br J Clin Pharmacol; 1982 Sep; 14(3):453-5. PubMed ID: 7126419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of phospholipids on mebendazole pharmacokinetics in experimental multilocular echinococcosis].
    Lur'e AA; Dzhabarova VI; Krotov AI; Shcherbakov AM
    Med Parazitol (Mosk); 1986; (5):67-71. PubMed ID: 3796459
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of the intraperitoneal administration of mebendazole on the immune reactions of mice with experimental hydatid disease].
    Kovrova EA; Frol'tsova AE; Leĭkina ES; Krotov AI
    Med Parazitol (Mosk); 1979; 48(1):78-82. PubMed ID: 431502
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mebendazole in the treatment of the acute and chronic stages of helminthiases. II. Mebendazole (Vermox) in the treatment of alveolar hydatid disease and echinococcosis].
    Tumol'skaia NI; Ozeretskovskaia NN; Zorikhina VI; Sivakov AE; Kudriashova NM
    Med Parazitol (Mosk); 1979; 48(5):17-24. PubMed ID: 537579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability].
    Dzhabarova VI; Dobrotvorskiĭ AE; Krotov AI
    Med Parazitol (Mosk); 1989; (5):43-6. PubMed ID: 2615711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental therapy of alveolar hydatid disease. VI. The effect of mebendazole particle size on its toxicity and effectiveness in laboratory animals when administered by various methods].
    Krotov AI; Frol'tsova AE; Dzhabarova VI; Tret'iakov SA; Egorova GG
    Med Parazitol (Mosk); 1978; 47(6):48-50. PubMed ID: 723808
    [No Abstract]   [Full Text] [Related]  

  • 18. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man.
    Dawson M; Braithwaite PA; Roberts MS; Watson TR
    Br J Clin Pharmacol; 1985 Jan; 19(1):79-86. PubMed ID: 3978023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukopenia associated with mebendazole therapy of hydatid disease.
    Miskovitz PF; Javitt NB
    Am J Trop Med Hyg; 1980 Nov; 29(6):1356-8. PubMed ID: 7446825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mebendazole in surgical and non-operative management of hydatid disease.
    Chevis RA
    Med J Aust; 1976 Oct; 2(15):580. PubMed ID: 994970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.